{
    "id": 23215,
    "fullName": "PIK3CA N345T",
    "impact": "missense",
    "proteinEffect": "gain of function - predicted",
    "geneVariantDescriptions": [
        {
            "description": "PIK3CA N345T lies within the C2 PI3K-type domain of the Pik3ca protein (UniProt.org). N345T has not been biochemically characterized, but is predicted to confer a gain of function on the Pik3ca protein as demonstrated by increased transformation ability in two different cell lines (PMID: 29533785).",
            "references": [
                {
                    "id": 295,
                    "pubMedId": null,
                    "title": null,
                    "url": "https://www.uniprot.org"
                },
                {
                    "id": 11238,
                    "pubMedId": 29533785,
                    "title": "Systematic Functional Annotation of Somatic Mutations in Cancer.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/29533785"
                }
            ]
        }
    ],
    "type": null,
    "gene": {
        "id": 5290,
        "geneSymbol": "PIK3CA",
        "terms": [
            "PIK3CA",
            "CLAPO",
            "CLOVE",
            "CWS5",
            "MCAP",
            "MCM",
            "MCMTC",
            "p110-alpha",
            "PI3K",
            "PI3K-alpha"
        ]
    },
    "variant": "N345T",
    "createDate": "06/14/2016",
    "updateDate": "04/29/2018",
    "referenceTranscriptCoordinates": {
        "id": 172023,
        "transcript": "NM_006218",
        "gDna": "chr3:g.179203764A>C",
        "cDna": "c.1034A>C",
        "protein": "p.N345T",
        "sourceDb": "RefSeq",
        "refGenomeBuild": "GRCh38/hg38"
    },
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 13078,
            "approvalStatus": "Clinical Study - Cohort",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a clinical study (AMNESIA-1), assessment of pre-treatment tumor samples from ERBB2 (HER2)-positive gastric or gastroesophageal cancer patients (defined as HER2 IHC 3+ or HER2 IHC 2+/ISH+) identified PIK3CA mutations in 15% (3/20) of patients demonstrating primary resistance to Herceptin (trastuzumab), including 1 patient harboring PIK3CA N345T (PMID: 29208673).",
            "molecularProfile": {
                "id": 28995,
                "profileName": "ERBB2 over exp PIK3CA N345T"
            },
            "therapy": {
                "id": 947,
                "therapyName": "Trastuzumab",
                "synonyms": null
            },
            "indication": {
                "id": 10534,
                "name": "stomach cancer",
                "source": "DOID"
            },
            "responseType": "predicted - resistant",
            "references": [
                {
                    "id": 10846,
                    "pubMedId": 29208673,
                    "title": "Biomarkers of Primary Resistance to Trastuzumab in HER2-Positive Metastatic Gastric Cancer Patients: the AMNESIA Case-Control Study.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/29208673"
                }
            ],
            "ampCapAscoEvidenceLevel": "C",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 23894,
            "profileName": "PIK3CA N345T",
            "profileTreatmentApproaches": [
                {
                    "id": 18169,
                    "name": "PI3K Inhibitor (Pan)",
                    "profileName": "PIK3CA N345T"
                },
                {
                    "id": 18170,
                    "name": "mTORC2 Inhibitor",
                    "profileName": "PIK3CA N345T"
                },
                {
                    "id": 18172,
                    "name": "mTOR Inhibitor",
                    "profileName": "PIK3CA N345T"
                },
                {
                    "id": 18174,
                    "name": "Akt Inhibitor (Pan)",
                    "profileName": "PIK3CA N345T"
                },
                {
                    "id": 18171,
                    "name": "Akt1 Inhibitor",
                    "profileName": "PIK3CA N345T"
                },
                {
                    "id": 18173,
                    "name": "Akt2 Inhibitor",
                    "profileName": "PIK3CA N345T"
                },
                {
                    "id": 18168,
                    "name": "PIK3CA inhibitor",
                    "profileName": "PIK3CA N345T"
                },
                {
                    "id": 18167,
                    "name": "mTORC1 Inhibitor",
                    "profileName": "PIK3CA N345T"
                }
            ]
        },
        {
            "id": 28955,
            "profileName": "ERBB2 pos PIK3CA N345T",
            "profileTreatmentApproaches": [
                
            ]
        },
        {
            "id": 28995,
            "profileName": "ERBB2 over exp PIK3CA N345T",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        {
            "id": 172024,
            "transcript": "XM_011512894",
            "gDna": "chr3:g.179203764A>C",
            "cDna": "c.1034A>C",
            "protein": "p.N345T",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 172023,
            "transcript": "NM_006218",
            "gDna": "chr3:g.179203764A>C",
            "cDna": "c.1034A>C",
            "protein": "p.N345T",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 172022,
            "transcript": "XM_006713658",
            "gDna": "chr3:g.179203764A>C",
            "cDna": "c.1034A>C",
            "protein": "p.N345T",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        }
    ]
}